References
Aronoff SC, Reed MD, O’Brien CA, Blumer JL. Comparison of the efficacy and safety of ceftriaxone to ampicillin/chloramphenicol in the treatment of childhood meningitis. Journal of Antimicrobial Chemotherapy 13: 143–151, 1984
Asmar BI, Thirumoorthi MC, Buckley JA, Kobos DM, Dajani AS. Cefotaxime diffusion into cerebrospinal fluid of children with meningitis. Antimicrobial Agents and Chemotherapy 28: 138–140, 1985
Barry AL, Thornsberry C. Susceptibility testing: diffusion test procedure. In Lennette et al. (Eds) Manual of Clinical Microbiology, Vol. 3, pp. 463–474, American Society for Microbiology, Washington DC, 1980
Barson WJ, Miller MA, Brady MT, Powell DA. Prospective comparative trial of ceftriaxone vs conventional therapy for treatment of bacterial meningitis in children. Pediatric Infectious Disease 4: 362–368, 1985
Bégué P, Floret D, Mallet E, Raynaud EJ, Safran C, et al. Pharmacokinetics and clinical evaluation of cefotaxime in children suffering with purulent meningitis. Journal of Antimicrobial Chemotherapy 14 (Suppl. B): 161–165, 1984
Belohradsky BH, Bruch K, Geiss D, Kafetzis D, Marget W, et al. Intravenous cefotaxime in children with bacterial meningitis. Lancet 1: 61–63, 1980
Borderon JC, Despert F, Santini JJ, Laugier J, Grenier B, et al. Le cefotaxime dans le traitement des méningites purulentes de l’enfant. Nouvelle Presse Médicale 10: 634–638, 1981
Campos J, Garcia-Tornel S, Gairi JM, Fabregues J. Multiply resistant Haemophilus influenzae type b causing meningitis: comparative clinical and laboratory study. Journal of Pediatrics 108: 897–902, 1986
Catlin BW. Iodometric detection of Haemophilus influenzae beta-lactamase: rapid presumptive test for ampiciliin resistance. Antimicrobial Agents and Chemotherapy 7: 265–270, 1975
Chartrand SA, Marks MI, Scribner RK, Johnston JT, Frederick DF. Moxalactam therapy of Haemophilus influenzae type b meningitis in children. Journal of Pediatrics 104: 454–459, 1984
Congeni BL. Comparison of ceftriaxone and traditional therapy of bacterial meningitis. Antimicrobial Agents and Chemotherapy 25: 40–44, 1984
Del Rio MdlA, Chrane D, Shelton S, McCracken GH, Nelson JD. Ceftriaxone versus ampiciliin and chloramphenicol for treatment of bacterial meningitis in children. Lancet 1: 1241–1244, 1983
Fraise AP, Meeks ACG, Richards JE. Meningitis due to Haemophilus influenzae resistant to ampiciliin and chloramphenicol. Archives of Disease in Childhood 61: 1134–1135, 1986
Jacobs RF, Wells TG, Steele RW, Yamauchi T. A prospective randomized comparison of cefotaxime vs ampiciliin and chloramphenicol for bacterial meningitis in children. Journal of Pediatrics 107: 129–133, 1985
Kaplan SL, Mason EO, Mason SK, Catlin FI, Murphy M, et al. Prospective comparative trial of moxalactam versus ampiciliin or chloramphenicol for treatment of Haemophilus influenzae type b meningitis in children. Journal of Pediatrics 104: 447–453, 1984
Kilian M. Haemophilus. In Lennette et al. (Eds) Manual of Clinical Microbiology, Vol. 3, pp. 330–336, American Society for Microbiology, Washington DC, 1980
Lapointe JR, Beliveau C, Chicoine L, Joncas JH. A comparison of ampicillin-cefotaxime and ampicillin-chloramphenicol in childhood bacterial meningitis: an experience in 55 patients. Journal of Antimicrobial Chemotherapy 14 (Suppl. B): 167–180, 1984
Lapointe JR, Beyeler S. Susceptibility of 114 clinically significant Haemophilus influenzae strains to ampiciliin, chloramphenicol, rifampin, erythromycin, 2nd and 3rd generation cephalosporins. Canadian Journal of Public Health 76: 25–29, 1985
Neu HC. The new beta-lactamase stable cephalosporins. Annals of Internal Medicine 97: 408–419, 1982
Neu HC. Use of cephalosporins in the treatment of bacterial meningitis. In Sande et al. (Eds) Contemporary issues in Infectious Diseases: Bacterial Meningitis, Vol. 3, pp. 203–217, Churchill Livingstone, New York, 1985
Odio CM, Faingezicht I, Salas JL, Guevara J, Mohs E, et al. Cefotaxime vs conventional therapy for the treatment of bacterial meningitis in infants and children. Pediatric Infectious Disease 5: 402–407, 1986
Pesnel G, Squinazi F, Lemerle-Gruson S, Geslin P, Reinert PH. Cefotaxime et meningites à Haemophilus influenzae de l’enfant. Annales de Pédiatric 31: 281–285, 1984
Rodriguez WJ, Puig JR, Khan WN, Feris J, Gold BG, et al. Ceftazidime vs standard therapy for pediatric meningitis: therapeutic, pharmacologie and epidemiologic observations. Pediatric Infectious Disease 5: 408–415, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lapointe, JR., Chicoine, L. Cefotaxime versus Chloramphenicol for Ampicillin-Resistant Haemophilus influenzae Meningitis. Drugs 35 (Suppl 2), 199–202 (1988). https://doi.org/10.2165/00003495-198800352-00043
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800352-00043